Risk of Death in Colorectal Cancer Patients with Multi-morbidities of Metabolic Syndrome: A Retrospective Multicohort Analysis

PURPOSE: The prevalence of multi-morbidities with colorectal cancer (CRC) is known to be increasing. Particularly prognosis of CRC patients co-diagnosed with metabolic syndrome (MetSyn) was largely unknown. We aimed to examine the death risk of CRC patients according to the multiple MetSyn morbiditi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qingting, Xu, Lingkai, Li, Lin, Qiu, Junlan, Huang, Ziwei, Jiang, Yiqing, Wen, Tao, Lu, Shun, Meng, Fang, Shu, Xiaochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291199/
https://www.ncbi.nlm.nih.gov/pubmed/33285055
http://dx.doi.org/10.4143/crt.2020.481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291199/
https://www.ncbi.nlm.nih.gov/pubmed/33285055
http://dx.doi.org/10.4143/crt.2020.481

Ejemplares similares